| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |